Tarsus Pharmaceuticals, Inc. Common Stock (TARS) is a publicly traded Healthcare sector company. As of July 14, 2026, TARS trades at $59.25 with a market cap of $2.54B and a P/E ratio of -52.88. TARS moved +1.89% today. Year to date, TARS is -27.96%; over the trailing twelve months it is +51.38%. Its 52-week range spans $38.51 to $85.25. Analyst consensus is strong buy with an average price target of $94.29. Rallies surfaces TARS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for TARS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $59.25 |
| Market Cap | $2.54B |
| P/E Ratio | -52.88 |
| EPS | $-1.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $85.25 |
| 52-Week Low | $38.51 |
| Volume | 963.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $535.08M |
| Net Income | $-48.27M |
| Gross Margin | 0.00% |
8 analysts cover TARS: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $94.29.